Methylenedioxymethamphetamine suppresses production of the proinflammatory cytokine tumor necrosis factor-α independent of a β-adrenoceptor- mediated increase in interleukin-10

Journal of Pharmacology and Experimental Therapeutics

Volumn 312, Issue 1, 2005, Pages 134-143

  Connor, Thomas J ^a,b   Harkin, Andrew ^b,c   Kelly, John P ^b  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^c UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; BACTERIUM LIPOPOLYSACCHARIDE; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CATECHOLAMINE; GLUCOCORTICOID; INTERLEUKIN 10; OXIDOPAMINE; TUMOR NECROSIS FACTOR ALPHA;

ADRENALECTOMY; ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHEMICAL SYMPATHECTOMY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; ENZYME INHIBITION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RAT;

ADRENALECTOMY; ADRENERGIC ANTAGONISTS; ADRENERGIC UPTAKE INHIBITORS; ANIMALS; ANTI-INFLAMMATORY AGENTS; CATECHOLAMINES; GLUCOCORTICOIDS; INTERLEUKIN-10; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, BETA; SYMPATHECTOMY; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 11844255427     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.104.073023     Document Type: Article

References (40)

1. Arai T, Hiromatsu K, Kobayashi N, Takano M, Ishida H, Nimura Y, and Yoshikai Y (1995) IL-10 is involved in the protective effect of dibutyryl cyclic adenosine monophosphate on endotoxin-induced inflammatory liver injury. J Immunol 155:5743-5749.
2. Avila AH, Morgan CA, and Bayer BM (2003) Stress-induced suppression of the immune system after withdrawal from chronic cocaine. J Pharmacol Exp Ther 305:290-297.
3. Bencsics A, Elenkov IJ, and Vizi ES (1997) Effect of morphine on lipopolysaccharide-induced tumor necrosis factor-α production in vivo: involvement of the sympathetic nervous system. J Neuroimmunol 73:1-6.
4. Bogdan C, Paik J, Vodovotz Y, and Nathan C (1992) Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-β and interleukin-10. J Biol Chem 267:23301-23308.
5. Cartmell T, Ball C, Bristow AF, Mitchell D, and Poole S (2003) Endogenous interleukin-10 is required for the defervescence of fever evoked by local lipopolysaccharide-induced and Staphylococcus aureus-induced inflammation in rats. J Physiol 549:653-664.
6. Connor TJ (2004) Methylenedioxymethamphetamine (MDMA; "Ecstasy"): a stressor on the immune system. Immunology 111:357-367.
7. Connor TJ, Dennedy MC, Harkin A, and Kelly JP (2001) Methylenedioxymethamphetamine-induced suppression of interleukin-1β and tumour necrosis factor-α is not mediated by serotonin. Eur J Pharmacol 418:147-152.
8. Connor TJ and Kelly JP (2002) Fenfluramine-induced immunosuppression: an in vivo analysis. Eur J Pharmacol 455:175-185.
9. Connor TJ, Kelly JP, McGee M, and Leonard BE (2000) Methylenedioxymethamphetamine (MDMA; Ecstasy) suppresses interleukin-1β and tumor necrosis factor-α secretion following an in vivo lipopolysaccharide challenge. Life Sci 67:1601-1612.
10. Connor TJ, McNamara MG, Finn D, Currid A, O'Malley M, Redmond AM, Kelly JP, and Leonard BE (1998) Acute 3,4-methylenedioxymethamphetamine (MDMA) administration produces a rapid and sustained suppression of immune function in the rat. Immunopharmacology 38:253-260.
11. de Waal Malefyt R, Haanen J, Spits H, Roncarolo MG, te Velde A, Figdor C, Johnson K, Kastelein R, Yssel H, and de Vries JE (1991) Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 174:915-924.
12. Ding L, Linsley PS, Huang LY, Germain RN, and Shevach EM (1993) IL-10 inhibits macrophage co-stimulatory activity by selectively inhibiting the up-regulation of B7 expression. J Immunol 151:1224-1234.
13. Elenkov IJ, Hasko G, Kovacs KJ, and Vizi ES (1995) Modulation of lipopolysaccharide-induced tumor necrosis factor-α production by selective α- and β-adrenergic drugs in mice. J Neuroimmunol 61:123-131.
14. Elenkov IJ, Wilder RL, Chrousos GP, and Vizi ES (2000) The sympathetic nerve: an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev 52:595-638.
15. Exton MS, Gierse C, Meier B, Mosen M, Xie Y, Frede S, Goebel MU, Limmroth V, and Schedlowski M (2002) Behaviorally conditioned immunosuppression in the rat is regulated via noradrenaline and β-adrenoceptors. J Neuroimmunol 131:21-30.
16. Gerard C, Bruyns C, Marchant A, Abramowicz D, Vandenabeele P, Delvaux A, Fiers W, Goldman M, and Velu T (1993) Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med 177:547-550.
17. Green AR, Mechan AO, Elliott JM, O'Shea E, and Colado MI (2003) The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). Pharmacol Rev 55:463-508.
18. Grob SC, Russell EP, Chang L, and Ernst T (1996) Psychobiologic effects of 3,4-methylenedioxymethamphetamine in humans: methodological considerations and preliminary observations. Behav Brain Res 73:103-107.
19. Hamblin AS (1994) Cytokines, in Textbook of Immunopharmacology (Dale MM, Foreman JC and Fan TD eds), 3rd ed. pp 179-192, Blackwell Scientific Publications, Oxford, UK.
20. Hasko G, Szabo C, Nemeth ZH, and Deitch EA (2002) Dopamine suppresses IL-12 p40 production by lipopolysaccharide-stimulated macrophages via a β-adrenoceptor-mediated mechanism. J Neuroimmunol 122:34-39.
21. Hawes AS, Rock CS, Keogh CV, Lowry SF, and Calvano SE (1992) In vivo effects of the antiglucocorticoid RU 486 on glucocorticoid and cytokine responses to Escherichia coli endotoxin. Infect Immun 60:2641-2647.
22. Houghtling RA and Bayer BM (2002) Rapid elevation of plasma interleukin-6 by morphine is dependent on autonomic stimulation of adrenal gland. J Pharmacol Exp Ther 300:213-219.
23. Langeneckert W and Palm D (1968) Formation of the β-adrenergic 3′-deoxy-3-methyl-tetrahydropapaveroline from α-methyldopamine and tyramine by incubation with monoamine oxidase preparations. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol 260:400-415.
24. Monks TJ, Jones DC, Bai F, and Lau SS (2004) The role of metabolism in 3,4-(+)-methylenedioxyamphetamine and 3,4-(+)-methylenedioxymethamphetamine (ecstasy) toxicity. Ther Drug Monit 26:132-136.
25. Moore KW, de Waal Malefyt R, Coffman RL, and O'Garra A (2001) Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19:683-765.
26. Nash JF Jr, Meltzer HY, and Gudelsky GA (1988) Elevation of serum prolactin and corticosterone concentrations in the rat after the administration of 3,4-methylenedioxymethamphetamine. J Pharmacol Exp Ther 245:873-879.
27. Pacifici R, Pichini S, Zuccaro P, Farre M, Segura M, Ortuno J, Di Carlo S, Bacosi A, Roset P, Segura J, et al. (2004) Paroxetine inhibits acute effects of MDMA on the immune system in humans. J Pharmacol Exp Ther 309:285-292.
28. Pacifici R, Zuccaro P, Farre M, Pichini S, Di Carlo S, Roset PN, Ortuno J, Pujadas M, Bacosi A, Menoyo E, et al. (2001a) Effects of repeated doses of MDMA ("ecstasy") on cell-mediated immune response in humans. Life Sci 69:2931-2941.
29. Pacifici R, Zuccaro P, Hernandez Lopez C, Pichini S, Di Carlo S, Farre M, Roset PN, Ortuno J, Segura J, and de la Torre R (2001b) Acute effects of 3,4-methylenedioxymethamphetamine alone and in combination with ethanol on the immune system in humans. J Pharmacol Exp Ther 296:207-215.
30. Pasparakis M, Alexopoulou L, Episkopou V, and Kollias G (1996) Immune and inflammatory responses in tumor necrosis factor-α deficient mice: a critical requirement for tumor necrosis factor alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers and in the maturation of the humoral immune response. J Exp Med 184:1397-1411.
31. Pezzone MA, Rush KA, Kusnecov AW, Wood PG, and Rabin BS (1992) Corticosterone-independent alteration of lymphocyte mitogenic function by amphetamine. Brain Behav Immun 6:293-299.
32. Ruffolo RR Jr, Messick K, and Horng JS (1984) Interactions of three inotropic agents, ASL-7022, dobutamine and dopamine, with α- and β-adrenoceptors in vitro. Naunyn Schmiedebergs Arch Pharmacol 326:317-326.
33. Shames BD, McIntyre RC Jr, Bensard DD, Pulido EJ, Selzman CH, Reznikov LL, Harken AH, and Meng X (2001) Suppression of tumor necrosis factor alpha production by cAMP in human monocytes: dissociation with mRNA level and independent of interleukin-10. J Surg Res 99:187-193.
34. Siegmund B, Eigler A, Hartmann G, Hacker U, and Endres S (1998) Adrenaline enhances LPS-induced IL-10 synthesis: evidence for protein kinase A-mediated pathway. Int J Immunopharmacol 20:57-69.
35. Smith SR, Terminelli C, and Denhardt G (2000) Effects of cannabinoid receptor agonist and antagonist ligands on production of inflammatory cytokines and anti-inflammatory interleukin-10 in endotoxemic mice. J Pharmacol Exp Ther 293:136-150.
36. Souza DG, Guabiraba R, Pinho V, Bristow A, Poole S, and Teixeira MM (2003) IL-1-driven endogenous IL-10 production protects against the systemic and local acute inflammatory response following intestinal reperfusion injury. J Immunol 170:4759-4766.
37. Stuerenburg HJ, Petersen K, Baumer T, Rosenkranz M, Buhmann C, and Thomasius R (2002) Plasma concentrations of 5-HT, 5-HIAA, norepinephrine, epinephrine and dopamine in ecstasy users. Neuro Endocrinol Lett 23:259-261.
38. Suzuki N, Suzuki S, Eriksson U, Hara H, Mirtosis C, Chen NJ, Wada T, Bouchard D, Hwang I, Takeda K, et al. (2003) IL-1R-associated kinase 4 is required for lipopolysaccharide-induced activation of APC. J Immunol 171:6065-6071.
39. Zinyama RB, Bancroft GJ, and Sigola LB (2001) Adrenaline suppression of the macrophage nitric oxide response to lipopolysaccharide is associated with differential regulation of tumour necrosis factor-α and interleukin-10. Immunology 104:439-446.
40. Zuckerman SH, Shellhaas J, and Butler LD (1989) Differential regulation of lipopolysaccharide-induced interleukin 1 and tumor necrosis factor synthesis: effects of endogenous and exogenous glucocorticoids and the role of the pituitary-adrenal axis. Eur J Immunol 19:301-305.